hopkins dsip The 2025 Diversity Summer Internship Program (DSIP) application at Johns Bloomberg School of Public Health is open now through February 1, 2025. If you have completed two years of college and I am pleased to announce
Description
Metseras recent announcement of positive Phase 2b data for MET-097i a First- and Best-in-Class Ultra-long Acting GLP-1 RA candidate marks an important step forward, with Phase 3 expected to begin in 2025
Dewachter I, Ris L, Croes S, Borghgraef P, Devijver H, Voets T, et al
2017;28(suppl_5):v26994
II, laxity with a firm endpoint and a stable arc of motion
Standard protocols use 0.25-0.5 mg (250-500 mcg) daily via subcutaneous injection
Opportunities Innovative Next Gen Drug Candidates The anti-obesity drugs market is poised for a transformative shift, driven by the emergence of next-generation drug candidates that offer enhanced efficacy, improved safety profiles, and greater patient convenience
